United States · FDA National Drug Code directory
VENLAFAXINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 71785-1006_b45cbdea-d1be-c16d-e053-2a95a90a821e
- Product NDC
- 71785-1006
- Form
- CAPSULE, EXTENDED RELEASE
- Composition / generic term
- VENLAFAXINE HYDROCHLORIDE
- Labeler
- Annora Pharma Private Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20190708
- Source listing expiry
- 20261231
Source-listed ingredients
- VENLAFAXINE HYDROCHLORIDE — 37.5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71785-1006-0) · 71785-1006-0
- 90 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71785-1006-1) · 71785-1006-1
- 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (71785-1006-2) · 71785-1006-2
- 10 BLISTER PACK in 1 CARTON (71785-1006-3) / 10 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK · 71785-1006-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →